Surgery Partners, Inc. Common Stock SGRY
$23.13
+0.04%
at last close
Analyst Consensus
- Consensus Rating
- Hold (2 Buy · 6 Hold · 0 Sell)
- Average Price Target
- $19.64
- Implied Upside
- -15.1%
- Price Target Range
- $14.00 – $25.00
- Analysts (12 mo)
- 8
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2026-11-11 | TD CowenRyan Langston |
Maintains | Hold | $24 → $25 |
| 2026-11-10 | RBC CapitalBen Hendrix |
Maintains | Sector perform | $24 → $25 |
| 2026-10-28 | UBSA.J. Rice |
Downgrades | Buy → Neutral | $21 → $24 |
| 2026-10-27 | StoneXBill Sutherland |
Downgrades | Buy → Hold | — |
| 2026-09-30 | RBC CapitalBen Hendrix |
Reiterates | Outperform | $19 |
| 2026-09-18 | TD CowenRyan Langston |
Reiterates | Buy | $19 |
| 2026-09-14 | JP MorganBenjamin Rossi |
Maintains | Neutral | $14 → $15 |
| 2026-08-11 | TD CowenRyan Langston |
Maintains | Buy | $17 → $19 |
| 2026-08-11 | RBC CapitalBen Hendrix |
Maintains | Outperform | $20 → $19 |
| 2026-08-11 | Cantor FitzgeraldSarah James |
Reiterates | Overweight | $18 |
| 2026-03-05 | TD CowenRyan Langston |
Maintains | Buy | $28 → $20 |
| 2026-03-05 | UBSA.J. Rice |
Maintains | Buy | $29 → $21 |
| 2026-03-05 | MizuhoAnn Hynes |
Maintains | Outperform | $19 → $17 |
| 2026-03-04 | RBC CapitalBen Hendrix |
Maintains | Outperform | $31 → $20 |
| 2026-03-03 | BarclaysAndrew Mok |
Maintains | Equal-weight | $18 → $14 |
| 2025-12-18 | MizuhoAnn Hynes |
Maintains | Outperform | $22 → $19 |
| 2025-11-24 | JP MorganBenjamin Rossi |
Maintains | Neutral | $27 → $20 |
| 2025-11-21 | BarclaysAndrew Mok |
Maintains | Equal-weight | $24 → $18 |
| 2025-11-17 | MizuhoAnn Hynes |
Maintains | Outperform | $28 → $22 |
| 2025-11-13 | UBSA.J. Rice |
Maintains | Buy | $34 → $29 |
| 2025-11-11 | RBC CapitalBen Hendrix |
Maintains | Outperform | $35 → $31 |
| 2025-11-11 | BenchmarkBill Sutherland |
Maintains | Buy | $35 → $30 |
| 2025-10-07 | Cantor FitzgeraldSarah James |
Reiterates | Overweight | $36 |
| 2025-09-18 | JP MorganBenjamin Rossi |
Assumes | Neutral | $27 |
| 2025-05-27 | BarclaysAndrew Mok |
Maintains | Equal-weight | $25 → $24 |
| 2025-04-21 | BenchmarkBill Sutherland |
Reiterates | Buy | $35 |
| 2025-03-25 | RBC CapitalBen Hendrix |
Reiterates | Outperform | $35 |
| 2025-03-11 | MacquarieTao Qiu |
Maintains | Outperform | $34 → $33 |
| 2024-12-03 | JP MorganLisa Gill |
Maintains | Neutral | $38 → $28 |
| 2024-11-20 | RBC CapitalBen Hendrix |
Maintains | Outperform | $49 → $35 |
Ratings and price targets reflect each firm's most recent published action. Consensus combines the latest call from every covering firm over the past 12 months; price targets are typically 12-month horizons.
Key Stats
- Last Close
- $23.13
- Market Cap
- $2.98 billion
- 52-Week Range
- $11.41 – $23.44
- Average Volume
- 4.29 million shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.